ArticleStem cell research & therapy2026
A non-invasive, patient-derived organoid platform from uterine lavage fluid for modeling endometrial implantation and disease.
Article in Stem cell research & therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors.
Funding
Abstract
backgroundEndometrial organoids, with their three-dimensional structure and robust hormonal responsiveness, have emerged as valuable models for investigating uterine physiology and embryo implantation. However, conventional derivation from endometrial biopsies is invasive, carries surgical risks, and limits repeated sampling. This study introduces uterine lavage fluid as a non-invasive source for generating endometrial organoids.
methodsWe established endometrial organoids from uterine lavage fluid (UF-EOs) and compared them with matched tissue-derived endometrial organoids (T-EOs) for morphology, proliferation, epithelial marker expression, transcriptomic profiles, and hormone responsiveness. Lavage fluid was collected from reproductive-age women with normal endometrium and from patients with intrauterine adhesions (IUA). Differential gene-expression analysis between IUA-derived and control organoids was performed to identify IUA-associated signatures. A microinjection platform was developed to deliver HTR8/SVneo trophoblast spheroids into the organoid lumen.
resultsUF-EOs were successfully derived from 90% of control individuals (9/10) and 60% of IUA patients (6/10). UF-EOs and T-EOs were morphologically indistinguishable, with comparable proliferation rates (104.6 ± 6.21 versus 106.4 ± 5.16; P > 0.05) and equivalent expression of epithelial markers (EpCAM, Cytokeratin 7, E-cadherin). Transcriptomic analysis showed tight paired clustering of UF-EOs with matched T-EOs across three independent patients. Both organoid types demonstrated equivalent hormone responsiveness, with progesterone-induced secretory differentiation evidenced by glandular folding, subnuclear vacuolization, glycogen accumulation, and upregulation of SPP1, PAEP, and 17HSDβ2. IUA-derived UF-EOs displayed 190 differentially expressed genes, with enrichment of cell cycle, TGF-β, and Hippo signaling pathways. TGF-β2 and Smad2 were significantly upregulated and SOX9, PCNA, and Ki67 were downregulated, consistent with compromised regenerative capacity. HTR8/SVneo spheroids were successfully microinjected into organoid lumens, with luminal localization observed at 24 h.
conclusionWe have introduced uterine lavage fluid as a feasible source for generating endometrial organoids with equivalent fidelity to tissue-derived counterparts. UF-EOs provide a non-invasive alternative that enables organoid-based research in populations previously excluded from invasive sampling, including patients with intrauterine adhesions. Our findings demonstrate applications in disease mechanism investigation, endometrial receptivity assessment, and modeling of early embryo-epithelium interactions. Future studies employing larger cohorts and integrated multicellular systems will be essential to validate the clinical utility of this approach.
Indexed as
Identifiers
42449408What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.